| Implication of trimethylamine N-oxide (TMAO) in disease: potential biomarker or new therapeutic target MH Janeiro, MJ Ramírez, FI Milagro, JA Martínez, M Solas Nutrients 10 (10), 1398, 2018 | 620 | 2018 |
| c-Jun N-terminal kinase (JNK) signaling as a therapeutic target for Alzheimer’s disease R Yarza, S Vela, M Solas, MJ Ramirez Frontiers in pharmacology 6, 321, 2016 | 444 | 2016 |
| Exploring Pharmacological Mechanisms of Lavender (Lavandula angustifolia) Essential Oil on Central Nervous System Targets V López, B Nielsen, M Solas, MJ Ramírez, AK Jäger Frontiers in pharmacology 8, 280, 2017 | 324 | 2017 |
| Myeloid-cell-derived VEGF maintains brain glucose uptake and limits cognitive impairment in obesity A Jais, M Solas, H Backes, B Chaurasia, A Kleinridders, S Theurich, ... Cell 165 (4), 882-895, 2016 | 260 | 2016 |
| CB2 receptor and amyloid pathology in frontal cortex of Alzheimer's disease patients M Solas, PT Francis, R Franco, MJ Ramirez Neurobiology of aging 34 (3), 805-808, 2013 | 222 | 2013 |
| Inflammation and gut-brain axis link obesity to cognitive dysfunction: plausible pharmacological interventions M Solas, FI Milagro, MJ Ramírez, JA Martínez Current opinion in pharmacology 37, 87-92, 2017 | 163 | 2017 |
| Interactions between age, stress and insulin on cognition: implications for Alzheimer's disease M Solas, B Aisa, MC Mugueta, J Del Río, RM Tordera, MJ Ramírez Neuropsychopharmacology 35 (8), 1664-1673, 2010 | 146 | 2010 |
| Treatment options in alzheimer s disease: the GABA story M Solas, E Puerta, M J Ramirez Current pharmaceutical design 21 (34), 4960-4971, 2015 | 141 | 2015 |
| Long lasting effects of early-life stress on glutamatergic/GABAergic circuitry in the rat hippocampus E Martisova, M Solas, I Horrillo, JE Ortega, JJ Meana, RM Tordera, ... Neuropharmacology 62 (5-6), 1944-1953, 2012 | 138 | 2012 |
| Serotonin 5-HT6 Receptor Antagonists in Alzheimer’s Disease: Therapeutic Rationale and Current Development Status H Ferrero, M Solas, PT Francis, MJ Ramirez CNS drugs 31, 19-32, 2017 | 108 | 2017 |
| HPA axis dysregulation associated to apolipoprotein E4 genotype in Alzheimer's disease FJ Gil-Bea, B Aisa, A Solomon, M Solas, M del Carmen Mugueta, ... Journal of Alzheimer’s Disease 22 (3), 829-838, 2010 | 95 | 2010 |
| Insulin levels are decreased in the cerebrospinal fluid of women with prodomal Alzheimer's disease FJ Gil-Bea, M Solas, A Solomon, C Mugueta, B Winblad, M Kivipelto, ... Journal of Alzheimer’s Disease 22 (2), 405-413, 2010 | 93 | 2010 |
| The paradox of neuronal insulin action and resistance in the development of aging‐associated diseases SM Steculorum, M Solas, JC Brüning Alzheimer's & Dementia 10, S3-S11, 2014 | 89 | 2014 |
| β-N-methylamino-l-alanine causes neurological and pathological phenotypes mimicking Amyotrophic Lateral Sclerosis (ALS): The first step towards an experimental model for … E de Munck, E Munoz-Saez, BG Miguel, MT Solas, I Ojeda, A Martinez, ... Environmental toxicology and pharmacology 36 (2), 243-255, 2013 | 87 | 2013 |
| Stress‐induced anhedonia is associated with an increase in Alzheimer's disease‐related markers A Briones, S Gagno, E Martisova, M Dobarro, B Aisa, M Solas, R Tordera, ... British journal of pharmacology 165 (4), 897-907, 2012 | 78 | 2012 |
| Metabolic syndrome as a risk factor for Alzheimer’s disease: a focus on insulin resistance A Ezkurdia, MJ Ramírez, M Solas International journal of molecular sciences 24 (5), 4354, 2023 | 71 | 2023 |
| Brain metabolic alterations in Alzheimer’s disease CG Ardanaz, MJ Ramírez, M Solas International journal of molecular sciences 23 (7), 3785, 2022 | 63 | 2022 |
| Cholinergic hypofunction impairs memory acquisition possibly through hippocampal Arc and BDNF downregulation FJ Gil‐Bea, M Solas, L Mateos, B Winblad, MJ Ramírez, ... Hippocampus 21 (9), 999-1009, 2011 | 61 | 2011 |
| Stress contributes to the development of central insulin resistance during aging: implications for Alzheimer’s disease M Solas, B Aisa, RM Tordera, MC Mugueta, MJ Ramírez Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1832 (12 …, 2013 | 59 | 2013 |
| Precision obesity treatments including pharmacogenetic and nutrigenetic approaches M Solas, FI Milagro, D Martínez-Urbistondo, MJ Ramirez, JA Martínez Trends in Pharmacological Sciences 37 (7), 575-593, 2016 | 56 | 2016 |
Fermin I. Milagro (ORCID: 0000-0002-...Dept. Nutrition, Food Sciences and Physiology; Center for Nutrition Research; University of Navarraยืนยันอีเมลแล้วที่ unav.es